Table 2.
Perioperative usage of antiepileptic drugs in patients with brain tumors (39 institutes responded to the survey)
| Preoperative usage | Intraoperative usage | Postoperative usage | ||||
|---|---|---|---|---|---|---|
| No epileptic history | Epileptic history | No epileptic history | Epileptic history | No epileptic history | Epileptic history | |
| No usage of antiepileptic drugs | 13 (33.3%) | 1 (2.6%) | 17 (43.6%) | 13 (33.3%) | 19 (48.7%) | 0 (0%) |
| Usage of antiepileptic drugs | 26 (66.7%) | 38 (97.4%) | 22 (56.4%) | 26 (66.7%) | 20 (51.3%) | 39 (100%) |
| Breakdown list (multiple answers possible) | ||||||
| LEV | 24 | 38 | 7 (div) | 11 (div) | 19 | 37 |
| LCM | 3 | 14 | 0 | 1 (div) | 7 | 20 |
| PHT (fosPHT) | 3 | 5 | 16 (div) | 14 (div) | 3 | 3 |
| VPA | 3 | 4 | 0 | 0 | 2 | 4 |
| CBZ | 1 | 10 | 0 | 0 | 3 | 5 |
| LTG | 1 | 3 | 0 | 0 | 2 | 2 |
| PER | 1 | 6 | 0 | 0 | 3 | 11 |
LEV, Levetiracetam; LCM, Lacosamide; PHT, Phenytoin; fosPHT, Fosphenytoin; VPA, Sodium valproate; CBZ, Carbamazepine; LTG, Lamotrigine; PER, Perampanel hydrate; div, drip infusion in vein